Voriconazole Tablet Franchise in Ahmedabad

Antifungal Tablet Supplier in Mumbai

Fungal Infection Treatment Tablet Distributor in Hyderabad

Hospital & Clinic Medicine PCD Pharma Franchise in Jaipur

Voriconazole Tablet Stockist in Mumbai
Antifungal Medicine Export & Manufacturing in Chandigarh

Home/Products /voriconazole-200mg-tablet

Voricole 200 Tablet

Composition : Voriconazole (200mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Voricole 200 Tablet contains Voriconazole 200mg, a triazole antifungal agent used for the treatment of serious and invasive fungal infections. It is commonly prescribed in cases where rapid and effective antifungal action is required.

Voriconazole works by inhibiting fungal cell membrane synthesis, leading to disruption of fungal growth and elimination of infection. It is effective against a wide range of fungal pathogens, including Aspergillus and Candida species.

This tablet is frequently used in the management of invasive aspergillosis, candidemia, and other severe systemic fungal infections, especially in immunocompromised patients and hospital-based care settings.

Voricole 200 Tablet is valued for its strong clinical efficacy, reliable antifungal coverage, and consistent therapeutic outcomes. Its role in managing life-threatening fungal infections makes it an essential component of advanced antifungal therapy portfolios.

Read More

About the Product

Voricole 200 Tablet contains Voriconazole 200mg, a triazole antifungal agent used for the treatment of serious and invasive fungal infections. It is commonly prescribed in cases where rapid and effective antifungal action is required.

Voriconazole works by inhibiting fungal cell membrane synthesis, leading to disruption of fungal growth and elimination of infection. It is effective against a wide range of fungal pathogens, including Aspergillus and Candida species.

This tablet is frequently used in the management of invasive aspergillosis, candidemia, and other severe systemic fungal infections, especially in immunocompromised patients and hospital-based care settings.

Voricole 200 Tablet is valued for its strong clinical efficacy, reliable antifungal coverage, and consistent therapeutic outcomes. Its role in managing life-threatening fungal infections makes it an essential component of advanced antifungal therapy portfolios.

Common side effects include nausea, vomiting, diarrhea, headache, dizziness, visual disturbances, and mild liver enzyme elevations. Rarely, it may cause severe liver toxicity, heart rhythm changes, or allergic reactions.

Voricole 200 Tablet is indicated for the treatment of invasive aspergillosis, serious Candida infections, esophageal candidiasis, and other severe fungal infections in immunocompromised or critically ill patients. It is prescribed when infections are resistant to or unsuitable for other antifungal therapies.

Voricole 200 Tablet should be taken strictly as prescribed, usually on an empty stomach. Regular monitoring of liver function may be required during treatment. Avoid excessive sunlight exposure due to the risk of photosensitivity. Inform your doctor about all medications being taken to prevent potential drug interactions.

Store in a cool, dry place below 25°C, away from sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation